Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
08 2019
Historique:
received: 23 07 2018
accepted: 15 05 2019
pubmed: 19 6 2019
medline: 20 11 2019
entrez: 19 6 2019
Statut: ppublish

Résumé

Innate lymphoid cells (ILCs) are tissue-resident lymphocytes categorized on the basis of their core regulatory programs and the expression of signature cytokines. Human ILC3s that produce the cytokine interleukin-22 convert into ILC1-like cells that produce interferon-γ in vitro, but whether this conversion occurs in vivo remains unclear. In the present study we found that ILC3s and ILC1s in human tonsils represented the ends of a spectrum that included additional discrete subsets. RNA velocity analysis identified an intermediate ILC3-ILC1 cluster, which had strong directionality toward ILC1s. In humanized mice, the acquisition of ILC1 features by ILC3s showed tissue dependency. Chromatin studies indicated that the transcription factors Aiolos and T-bet cooperated to repress regulatory elements active in ILC3s. A transitional ILC3-ILC1 population was also detected in the human intestine. We conclude that ILC3s undergo conversion into ILC1-like cells in human tissues in vivo, and that tissue factors and Aiolos were required for this process.

Identifiants

pubmed: 31209406
doi: 10.1038/s41590-019-0425-y
pii: 10.1038/s41590-019-0425-y
pmc: PMC6685551
mid: NIHMS1039505
doi:

Substances chimiques

IFNG protein, human 0
IKZF3 protein, human 0
Interleukins 0
T-Box Domain Proteins 0
T-box transcription factor TBX21 0
Ikaros Transcription Factor 148971-36-2
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

980-991

Subventions

Organisme : NCI NIH HHS
ID : R01 CA188286
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR073752
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI106697
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA091842
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000448
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE025884
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK052574
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI095542
Pays : United States
Organisme : NIDDK NIH HHS
ID : K99 DK118110
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134035
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Eur J Immunol. 2018 Jul;48(7):1174-1180
pubmed: 29524223
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Eur J Immunol. 2019 Sep;49(9):1344-1355
pubmed: 31151137
EMBO J. 1999 Jun 1;18(11):3090-100
pubmed: 10357820
Nat Immunol. 2011 Nov 20;13(2):144-51
pubmed: 22101730
Immunity. 2017 May 16;46(5):760-761
pubmed: 28514678
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Nature. 2016 Apr 7;532(7597):127-30
pubmed: 26909574
Immunity. 2018 May 15;48(5):1060
pubmed: 29768165
Nature. 2019 Apr;568(7752):405-409
pubmed: 30944470
J Exp Med. 2012 Dec 17;209(13):2331-8
pubmed: 23209316
Immunity. 2015 Jul 21;43(1):146-60
pubmed: 26187413
Nat Rev Immunol. 2016 Mar;16(3):149-63
pubmed: 26875830
Immunity. 2010 Nov 24;33(5):736-51
pubmed: 21093318
Elife. 2017 Jan 16;6:
pubmed: 28079019
Nat Immunol. 2012 Jul 01;13(8):770-7
pubmed: 22751139
Nat Biotechnol. 2014 Apr;32(4):364-72
pubmed: 24633240
Nat Immunol. 2016 Apr;17(4):451-60
pubmed: 26878113
Nat Biotechnol. 2013 Jun;31(6):545-52
pubmed: 23685480
Eur J Immunol. 2015 Aug;45(8):2171-82
pubmed: 26031799
Front Immunol. 2017 Nov 16;8:1569
pubmed: 29201028
EMBO J. 2014 Nov 18;33(22):2721-34
pubmed: 25319415
Sci Rep. 2017 Sep 21;7(1):12099
pubmed: 28935867
Science. 2016 Apr 22;352(6284):459-63
pubmed: 27102484
Nat Immunol. 2016 Jun 21;17(7):765-74
pubmed: 27328006
Immunity. 2018 Jun 19;48(6):1104-1117
pubmed: 29924976
Immunity. 2014 Sep 18;41(3):354-365
pubmed: 25238093
Immunity. 2018 Feb 20;48(2):214-226
pubmed: 29466754
Nat Immunol. 2013 Apr;14(4):389-95
pubmed: 23455676
Sci Rep. 2017 Jun 14;7(1):3501
pubmed: 28615725
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9626-E9634
pubmed: 29078283
Mucosal Immunol. 2015 Mar;8(2):340-51
pubmed: 25138665
Semin Immunol. 2016 Aug;28(4):368-76
pubmed: 27354353
Cell. 2016 May 19;165(5):1134-1146
pubmed: 27156452
Immunity. 2007 Mar;26(3):275-7
pubmed: 17376390
Nat Immunol. 2015 Mar;16(3):306-17
pubmed: 25621825
Immunity. 2017 Nov 21;47(5):820-833
pubmed: 29166586
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10961-6
pubmed: 20534450
Science. 2015 May 22;348(6237):aaa6566
pubmed: 25999512
Mol Cell Biol. 2010 Sep;30(17):4149-58
pubmed: 20566697
Sci Signal. 2016 May 03;9(426):ra45
pubmed: 27141929
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nature. 2013 Feb 14;494(7436):261-5
pubmed: 23334414
Sci Signal. 2016 May 03;9(426):ra46
pubmed: 27141930
Cell. 2016 Aug 25;166(5):1231-1246.e13
pubmed: 27545347
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Nat Rev Immunol. 2017 Nov;17(11):665-678
pubmed: 28804130
Cold Spring Harb Perspect Biol. 2018 Mar 1;10(3):
pubmed: 28432132
Immunity. 2018 Jun 19;48(6):1208-1219.e4
pubmed: 29858011
Immunity. 2017 May 16;46(5):756-757
pubmed: 28514676

Auteurs

Marina Cella (M)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Ramya Gamini (R)

Pfizer Worldwide Research and Development, Cambridge, MA, USA.

Cristiane Sécca (C)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Patrick L Collins (PL)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Department of Microbial Infection and Immunity, Ohio State University, Wexner School of Medicine, Columbus, OH, USA.

Shanrong Zhao (S)

Pfizer Worldwide Research and Development, Cambridge, MA, USA.

Vincent Peng (V)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Michelle L Robinette (ML)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Jorge Schettini (J)

Pfizer Worldwide Research and Development, Cambridge, MA, USA.

Konstantin Zaitsev (K)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Computer Technologies Department, ITMO University, St Petersburg, Russia.

William Gordon (W)

Pfizer Worldwide Research and Development, Cambridge, MA, USA.
Cogen Therapeutics, Cambridge, MA, USA.

Jennifer K Bando (JK)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Kentaro Yomogida (K)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Victor Cortez (V)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.

Catrina Fronick (C)

The McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.

Robert Fulton (R)

The McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.

Lih-Ling Lin (LL)

Pfizer Worldwide Research and Development, Cambridge, MA, USA.
Immunology and Inflammation, Sanofi, Cambridge, MA, USA.

Susan Gilfillan (S)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Richard A Flavell (RA)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.

Liang Shan (L)

Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA.

Maxim N Artyomov (MN)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Michael Bowman (M)

Pfizer Worldwide Research and Development, Cambridge, MA, USA.
Immunology and Inflammation, Sanofi, Cambridge, MA, USA.

Eugene M Oltz (EM)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Department of Microbial Infection and Immunity, Ohio State University, Wexner School of Medicine, Columbus, OH, USA.

Scott A Jelinsky (SA)

Pfizer Worldwide Research and Development, Cambridge, MA, USA. Scott.Jelinsky@pfizer.com.

Marco Colonna (M)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mcolonna@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH